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Protein prenylation is required for membrane
anchorage of small GTPases. Correct membrane
targeting is essential for their biological activity.
Signal output of the prenylated proto-oncogene
Ras in addition critically depends on its organization
into nanoscale proteolipid assemblies of the plasma
membrane, so called nanoclusters. While protein
prenylation is an establisheddrug target, only a hand-
ful of nanoclustering inhibitors are known, partially
due to the lack of appropriate assays to screen for
such compounds. Here, we describe three cell-
based high-throughput screening amenable Fo¨rster
resonance energy transfer NANOclustering and Pre-
nylation Sensors (NANOPS) that are specific for Ras,
Rho, and Rab proteins. Rab-NANOPS provides the
first evidence for nanoclustering of Rab proteins.
Using NANOPS in a cell-based chemical screen, we
now identify macrotetrolides, known ionophoric anti-
biotics, as submicromolar disruptors of Ras nano-
clustering and MAPK signaling.
INTRODUCTION
Spatial segregation of related signaling proteins between mem-
brane compartments is a hallmark of eukaryotic information pro-
cessing. Correct membrane targeting of signaling proteins often
relies on lipid modifications (Resh, 2006). Specific subcellular
targeting allows lipidated proteins to execute distinct functions,
through integration into spatially confined signaling networks
(Groves and Kuriyan, 2010; Kholodenko et al., 2010). Three
prenyltransferases, farnsesyl-transferase (FT), geranylgeranyl-
transferase-1 (GGT-1), and Rab-geranylgeranyl-transferase
(RabGGT) posttranslationally attach prenyl groups via a thioether
linkage to C-terminal cysteines on hundreds of signaling proteins
(Resh, 2006). The cysteine may be part of a recognition motif on
the protein substrate, known as the CAAX box. The CAAX box866 Chemistry & Biology 19, 866–874, July 27, 2012 ª2012 Elsevier L(for C, cysteine; A, aliphatic residue; X, any residue), is specifi-
cally recognized by FT and/or GGT-1, depending on its exact
composition (Nguyen et al., 2011; Roberts et al., 2008). In
contrast, RabGGT needs an accessory protein REP for recogni-
tion of the G-domain of Rab proteins (Andres et al., 1993; Goody
et al., 2005; Pylypenko et al., 2003). RabGGT transfers two
geranylgeranyl moieties to two C-terminal cysteines; however,
in some cases only a single cysteine is available for prenylation.
Recent studies demonstrated that the spatial distribution of
several lipid-modified proteins in the membrane is not random.
For instance, Ras GTPases and GPI anchored proteins form
nanoclusters on the plasma membrane (Hancock, 2006; Han-
cock and Parton, 2005). They are highly dynamic and display life-
times between 0.1 and 1 s. Ras nanoclusters contain only six to
eight Ras molecules and are only 6–20 nm in size (Plowman
et al., 2005; Prior et al., 2003). At steady state, 40% of Ras
proteins are found in nanoclusters. Importantly, isoform-specific
nanoclusters produce distinct signaling outputs, thus providing
another level of spatially segregated signaling. For example K-
ras but not H-ras nanoclusters preferentially recruit the effector
C-Raf (Plowman et al., 2008). As a result, K-ras signals stronger
through this effector than H-ras (Voice et al., 1999; Yan et al.,
1998). Moreover, Ras-nanoclusters act as highly sensitive signal
amplifiers, thus increasing the robustness of signal transmission
across the membrane (Tian et al., 2007). If nanoclustering is
disrupted, signal-transduction and transforming activity of the
proto-oncogene Ras are critically compromised (Paz et al.,
2001; Tian et al., 2007). This confirms that nanoclustering is an
indispensable feature of the Ras signaling architecture. While
nanoclusters are well characterized for Ras proteins, preliminary
evidence for nanoclustering of other lipidated proteins, such as
of Rho proteins, Src-family kinases, and heterotrimeric G
proteins exists (Abankwa and Vogel, 2007). Whether nanoclus-
ters are also formed by small GTPases of the Rab subfamily is
not known.
Clustering of these molecules was detected using Fo¨rster
Resonance Energy Transfer (FRET), which is suitable to measure
nanoscale proximities between fluorescently tagged molecules
(Vogel et al., 2006). Computational simulations and experimental
data have shown that the FRET efficiency of donor and acceptor
fluorophores that are distributed randomly or partially clusteredtd All rights reserved
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Figure 1. Nanoclustering-Based FRET Biosensors for the Detection
of Lipid Transferase and Nanoclustering Inhibitors
(A and B) Schematic representation of the FRET biosensors, composed of
lipid-modified membrane anchors fused to yellow and cyan fluorescent
protein variants (white and gray squares, respectively).
(C) By using different membrane anchoring polypeptides, biosensors with
specificity for three prenyltransferases were designed.
(D) Cytometric FRET analysis of BHK cells transfected with Ras-NANOPS
and exposed to the farnesyl transferase inhibitor FTI2628 (published
IC50[FTI2628] = 20 nM, see Table S2) (n = 3). Response is measured as
changes in the FRET value, Emax (Figure S7).
(E) Response of the same biosensor to 100 mM (= IC50) palmitoylation inhibitors
(n = 6) after 24 hr incubation. (D and E) Treatment with 5 mM compactin was
used as positive control (n = 19). Individual data points (gray dots) and their
mean values (horizontal black bars) with SEM are given. The number of
independent experiments, n, is given above. p levels (Student’s t test) are
noted above the bars and in addition asterisks denote confidence levels, as
explained in Experimental Procedures.
See also Figure S1.
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level and the donor-acceptor ratio (Berney and Danuser, 2003;
Kiskowski and Kenworthy, 2007). Thus, FRET was applied in
the recent years to study nanoclustering or nanodomain segre-
gation of a number of proteins, such as receptors and lipid
anchored proteins (Abankwa et al., 2008a; Goswami et al.,
2008; Kenworthy and Edidin, 1998; Kenworthy et al., 2000;
Meyer et al., 2006; Zacharias et al., 2002).
In line with their central role in extra- and intracellular signal
integration, mutational activation and overexpression of mem-
brane anchored signaling proteins have been associated with a
number of diseases including cancer. One successful thera-
peutic approach for counteracting overactivation of such
mutants is blocking their membrane anchorage through inhibi-
tion of the cognate lipid transferases. This has been successfully
achieved with the development of clinically tested FT inhibitors
(FTIs) and GGT-1 inhibitors (GGTIs) (Konstantinopoulos et al.,
2007; Sebti and Hamilton, 2000). However, for RabGGT, asChemistry & Biology 19,well as for myristoyl and palmitoyl transferases, only very few
potent and specific inhibitors exist. This can at least partially
be attributed to the lack of suitable high-throughput assays for
the identification of compounds that are active in vivo. Current
in vitro assays for lipid transferases suffer from high hit attrition
due to poor bioavailability, high cytotoxicity, and off-target
effects in the whole-cell context.
Here, we present a set of generic cell-based assays that
exploit the changes in FRET arising from the dense packing of
prenylated proteins into nanoclusters on their cognate
membranes. Using this technology, we identified a class of
natural products that inhibits nanoclustering of a H-ras-derived
biosensor and affects MAPK signaling.
RESULTS
Nanoclustering-Associated FRET Reports on Functional
Membrane Anchorage of Ras-Derived Probes
Although targeting protein prenylation in the context of neo-
plastic cellular growth has shown clinical efficacy, it inevitably
has a pleiotropic effect with poorly understood consequences.
As the formation of nanoclusters is critical for signaling of at least
Ras oncogenes (Paz et al., 2001; Tian et al., 2007), the disruption
(or prevention) of protein recruitment to nanoclusters may repre-
sent a more targeted approach of modulating cellular signaling.
We therefore set out to establish, whether nanoclustering is
a common feature of prenylated proteins and whether small
molecules can selectively modulate it. To this end, we sought
to design a generic in vivo assay to monitor nanoclustering and
detect prenylation inhibitors in vivo.
We have previously shown that flow cytometric FRET
measurements can detect membrane nanoclustering of lipi-
dated proteins in mammalian cell lines (Abankwa and Vogel,
2007). In our approach, prenylatable polypeptides are geneti-
cally tagged with the fluorescent proteins mCFP or mCitrine.
Both probes are coexpressed in mammalian cells, and the spon-
taneous organization of tagged molecules into nanoclusters is
detected using FRET. We reasoned that disruption of nanoclus-
tering, or loss of their membrane anchorage due to inhibition of
their lipid modification, would lead to a concomitant reduction
in FRET efficiency (Figure 1A).
Owing to its well-characterized nanoclustering properties
(Abankwa et al., 2008b; Rotblat et al., 2004), we chose the
extended membrane targeting sequence of the proto-oncogene
H-Ras as a sensing unit to construct our first FRET biosensor,
Ras-NANOcluster and Prenylation Sensor (Ras-NANOPS)
(Figures 1B and 1C). The extent of nanoclustering, and therefore
functional membrane anchorage, was quantified using flow cy-
tometry, by determining the characteristic nanoclustering FRET
parameter, Emax (Figure S7available online).
As the C terminus of H-Ras is modified by both farnesylation
and palmitoylation in vivo, we expected Ras-NANOPS to report
on the cellular activity of both farnesylation and palmitoylation
inhibitors, as it is well documented that inhibition of prenylation
also prevents subsequent palmitoylation (Hancock, 2003). We
found that the biosensor dose-dependently responded to FT
inhibitors such as FTI2628 (Figure 1D) and FTI277 (Figure S1A),
but not to the latter’s cell-impermeable prodrug form FTI276
(Figure S1B), or only weakly to inhibitors of the other866–874, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 867
Table 1. Comparison of Nanoclustering FRET of Rab Proteins:
Emax Values of Indicated Rab Isoforms Determined as Described
in Experimental Procedures
Rab-isoform Rab8a Rab23 Rab5aQ79L
Emax ± SD (n) 26.7 ± 0.9 (5) 17.6 ± 1.8 (4) 26.0 ± 3.3 (9)
Mean values with SD and number of independent experiments (n) are
given. See also Table S1.
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Figure 2. Rho-NANOPS Specifically Detects Cellular Steady-State
Activity of GGT-1
(A) Rho-NANOPS is designed by genetic fusion of the Rac1 membrane-
targeting motif to the C terminus of mCFP or mCitrine, which together form the
FRET biosensor.
(B) Cytometric FRET analysis of BHK cells transfected with Rho-NANOPS and
treated with a GGT-1 inhibitor, GGTI2147 (IC50 = 500 nM), which has >60-fold
in vivo selectivity for geranylgeranylated Rap-1 over farnesylated H-ras
(Vasudevan et al., 1999) (n = 4).
(C) Effect of a specific FT inhibitor FTI2628 (IC50 = 20 nM) as a control (n = 3).
Response is measured as changes in the FRET value, Emax. Treatment with
5 mM compactin was used a positive control (n = 19). Individual data points
(gray dots) and their mean values (horizontal black bars) with SEM are given.
The number of independent experiments, n, is given above.
Statistical analysis was performed as explained in Experimental Procedures.
See also Figure S2.
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knockdown of FT subunits also decreased FRET, however, to
a lesser extent than chemical inhibition of FT (Figure S1F). We
next determined, whether Ras-NANOPS could also report on
the steady-state activity of palmitoyltransferases. Treatment of
cells with the weak acylation inhibitors (Webb et al., 2000),
2-bromo- and 2-fluoro-palmitate for 24 hr, lead to a small change
and no change in the FRET response, respectively (Figure 1E).
Additional posttranslational modifications of the CAAX box,
such as proteolysis and carboxymethylation, did not show a
strong effect on the nanoclustering FRET (Supplemental Results,
Figures S1H and S1I). These results confirmed that Ras-
NANOPS could specifically and dose-dependently detect cell
permeable inhibitors of farnesylated or palmitoylated membrane
anchored proteins, such as H-ras.
Specific and Sensitive Detection of GGT-1 Inhibitors
by Rho-NANOPS Biosensor
We expanded the concept of using nanoclustering FRET as
readout for functional protein prenylation by designing a
biosensor for GGT-1 geranylgeranylated Rho GTPases (Rho-
NANOPS). Similar to Ras-NANOPS, we genetically fused the
membrane targeting sequence of Rac1 to mCFP and mCitrine
(Figure 2A). Inhibition of GGT-1 with two potent GGT-1 inhibitors
led to a strong and dose-dependent decrease of Emax (Figure 2B
and Figure S2A). Rho-NANOPS detected specific inhibition of
GGT-1, as neither the specific FT inhibitor FTI2628 (Figure 2C),
nor the RabGGT specific inhibitor NE10790 led to a significant
response (Figure S2C). As FT and GGT-1 share a common
a subunit but have specific b subunits (Seabra et al., 1991),
only knockdown of the GGT-1-specific but not of the FT-specific
b subunit decreased the Emax significantly (Figure S2D). In
conclusion, Rho-NANOPS can sensitively and specifically detect
inhibitors of functional membrane anchorage of Rho proteins,
such as inhibitors of GGT-1.
Nanoclustering of Rab Proteins on the Plasma
Membrane and on Intracellular Membranes
We next wanted to design a nanoclustering FRET biosensor
for functional membrane anchorage of the third major GTPase
subfamily, Rab proteins. Rabs play a key role in regulating
intracellular vesicle trafficking and several Rab proteins and
their lipid transferase, RabGGT itself, have been associated
with the progression of cancer (Lackner et al., 2005; Stenmark,
2009).
We hypothesized that Rab proteins with Ras-like features,
such as plasma-membrane targeting or mono prenylation-motif,
may also nanocluster. This turned our attention to plasma
membrane localized Rab8a, which contains a Ras-like CAAX
prenylation motif (CSLL) (Joberty et al., 1993). We analyzed868 Chemistry & Biology 19, 866–874, July 27, 2012 ª2012 Elsevier Lnanoclustering FRET of full-length Rab8a proteins that were
N-terminally tagged with mCFP or mCitrine. The observed
Emax level in the cells transfected with these constructs (Table
1) was very similar to that of Rho-NANOPS (Figure 2) and compa-
rable to that of previous Ras-derived constructs (Abankwa et al.,
2008b; Abankwa and Vogel, 2007). In order to delineate the
determinants of Rab8a nanoclustering, we studied two addi-
tional Rab8a mutants. Neither introduction of an additional
prenylatable cysteine on its C terminus, nor mutational activation
of Rab8a, altered the Emax value significantly (Table S1).
Consistent with our cytometric data, FRET imaging of cells
expressing Rab8a confirmed high levels of FRET on both the
plasma membrane and intracellular vesicles (Figure 3A). To
obtain independent evidence for Rab8a nanoclusters, we sub-
jected plasma membrane sheets prepared from BHK cells to
electron microscopic analysis. This technique, which was previ-
ously used to detect H-Ras nanoclusters (Prior et al., 2003),
involves isolation of the apical plasma membrane of transfected
cells grown on coverslips and immunolabeling of the exposed
cytoplasmic face of the membrane. The gold labeling pattern is
then analyzed in an unbiased fashion to determine thetd All rights reserved
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Figure 3. Rab Proteins Can Nanocluster on the Plasma Membrane
and Intracellular Membranes
(A) Sensitizes acceptor emission FRET imaging of BHK cells coexpressing
Rab8a constructs, which are N-terminally tagged with either mCFP or mCi-
trine. The distribution of the constructs by normal confocal imaging is shown
on the left for comparison. High FRET levels are black, while absence of FRET
corresponds to yellow, as indicated on the FRET-index lookup table under the
FRET image (Supplemental Experimental Procedures). Scale bar is 5 mm.
(B) Electron microscopic analysis of apical membrane sheets from BHK cells
expressing GFP-tagged Rab8a or Rab23. The proteins were labeled with anti-
GFP antibody and visualized with 5 nm immunogold staining. Ripley’s
K-function analysis was performed on n = 12 plasma membrane sheets for
both EGFP-Rab8a and EGFP-Rab23 (averaging 150 and 164 gold particles per
1 mm2, respectively). Nanoclustering can be recognized as the positive
deflection of the L(r)-r curve from 1, the 99% Confidence interval (CI).
Maximum positive deflection of L(r)-r values above the 99% CI indicates the
average cluster radius (nm).
(C) Matrix of Emax nanoclustering FRET values as obtained by cytometry FRET
of indicated constructs that were fluorescently labeled as described in (A).
Stronger nanoscale coclustering is highlighted in bold. Of note, Rab8a and
Rab23 coclustering FRET is as low as that of Rab8a/H-rasG12V, suggesting
that the two Rab-family proteins are in different nanodomains.
(D) FRET imaging of BHK cells expressing Rab5aQ79L-constructs, tagged as
in Figure 4A. Comparison of the fluorescence intensity image (left) and the
FRET image (right) shows that highly fluorescent hyperfused endosomal
vesicles show high FRET levels.
Scale bars are 5 mm. See also Figure S3.
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Chemistry & Biology 19,distribution of the gold particles. As can be seen in Figure 3B, this
analysis confirmed that Rab8a is forming nanoclusters, where
the gold label distribution has a characteristic average diameter
of 27 nm. In support of our initial hypothesis, we also demon-
strated by FRET- and electron microscopic-analysis nanoclus-
tering of Rab23, which is another Rab isoform that has Ras-like
features similar to Rab8a (Table 1 and Figures 3B and 3C). FRET-
based coclustering analysis of cells cotransfected with both
Rab8a and Rab23 indicated that these proteins populated
distinct membrane nanodomains (Figure 3C) (Abankwa et al.,
2008b). While Rab8a coclustered with itself with an Emax of
26.7 ± 0.4, the Emax of Rab8a and Rab23 coclustering is only
19.5 ± 0.7. Similar Emax differences were previously found for
H- and K-ras-derived polypetides that are laterally segregated
into functionally distinct nanoclusters (Abankwa et al., 2008b;
Abankwa and Vogel, 2007). FRET analysis of additional Rab
isoforms, Rab34 and Rab35, furthermore showed that not all
predominantly plasma membrane localized Rab isoforms have
high Emax levels (Table S1 and Figure S3A). Our data however
provided conclusive evidence for Rab nanoclustering on the
plasma membrane.
Next, we asked whether Rab nanoclustering occurs on
internal membranes, as hinted by our Rab8a FRET imaging
results. Rab5a controls endocytosis and early endosome
dynamics, and is one of the best-studied Rab GTPase. When
a constitutively active form of Rab5a (Rab5aQ79L) was ex-
pressed, Rab5 decorated hyperfused giant endosomes (Gal-
perin and Sorkin, 2003; Stenmark et al., 1994) (Figure 3D). Using
FRET imaging, we found that fluorescently tagged Rab5aQ79L
exhibits high FRET levels on these structures (Figure 3D). More-
over, it showed a correspondingly high nanoclustering FRET
Emax value, which was as high as that of the plasma membrane
localized Rab isoforms (Table 1). This strongly suggests that
Rab5a is organized into nanoclusters on internal cellular
membranes.
In conclusion, we have provided evidence for the existence of
Rab protein nanoclusters.
Rab-NANOPS Reports on the Steady-State Cellular
Activity of RabGGT
Having demonstrated that Rab proteins can form nanoclusters,
we searched systematically for a suitable Rab-construct as
FRET biosensor. We determined the change in the Emax of 10
different Rab proteins and mutants as candidate biosensors
before and after compactin treatment (Table S1). Compactin is
a statin that inhibits HMG-CoA reductase in the mevalonate
pathway leading to depletion of farnesyl- and geranylgeranyl
pyrophosphates that serve as substrates of protein prenyltrans-
ferases. We selected Rab5aQ79L as themost suitable biosensor
(hereafter, Rab-NANOPS) (Figure 4A), as it showed a high Emax
value and a 230% decrease of Emax after compactin treatment
(Table S1). Moreover, Rab-NANOPS showed a dose-dependent
and specific FRET response to chemical inhibition of RabGGT
activity by the weak but selective RabGGT inhibitor NE10790
(Figure 4C and Figures S4B–S4F). Specificity for RabGGT
activity was confirmed by the significant decrease of Emax after
RNAi-mediated ablation of RabGGT expression (Figure S4G).
Using an analogous Rab8a-derived biosensor, we could also
confirm that NE10790 is ineffective against monoprenylated866–874, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 869
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Figure 4. Rab-NANOPS Reveals Nanoclustering of Rab5aQ79L and
Specifically Detects Inhibitors of Rab Prenylation
(A and B) (A) Rab-NANOPS exhibited FRET levels consistent with nano-
clustering and (B) showed intense decoration of enlarged endosomal vesicles.
(C) FRET in BHK cells transiently expressing this biosensor was used to detect
inhibition of RabGGT by its specific inhibitor NE10790 (IC50 = 560 mM) (n = 3).
Treatment with 5 mMcompactin served as a positive control (n = 15). Individual
data points (gray dots) and their mean values (horizontal black bars) with SEM
are given. p levels (Student’s t test) are noted above the bars and in addition
asterisks denote confidence levels, as explained in Experimental Procedures.
See also Figure S4.
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summary, we have designed a FRET biosensor assay that can
detect the activity of RabGGT in cells. Moreover, we have
demonstrated that full-length proteins can be used as sensing
unit for the steady-state activity of lipid transferases in our nano-
clustering FRET-based assay.
Screening of a Natural Product Library Identifies
Macrotetrolides as Ras-Nanoclustering and Ras
Signaling Disrupting Agents
Due to our interest in novel inhibitors of aberrant Ras and Rab
signaling, we tested whether our Ras- and Rab-NANOPS assays
could be used for screening of chemical compound libraries. To
evaluate the sensitivity of our assay, we measured in BHK cells
the FRET response to the dose-dependent inhibition of protein
prenylation by compactin in a 96-well plate format using a stan-
dard automated flow cytometer (Figures S5D–S5G and S7).870 Chemistry & Biology 19, 866–874, July 27, 2012 ª2012 Elsevier LImportantly, the compactin activity was detected with a sensi-
tivity close to that obtained in HMG-CoA reductase in vitro
assays (Istvan and Deisenhofer, 2001) (Figures S5D and S5E)
andwas >1,000 timesmore sensitive than the evaluation of com-
pactin action by a cytotoxicity assay (Figure S5H). Moreover, our
cytometry FRET analysis was much more efficient than the eval-
uation of microscopic imaging data, where in high content
screening applications the subcellular relocalization is typically
assessed (Figure S6A). In addition, we validated the dependence
of the FRET response on the expression level and prenylation
state of the biosensors by acceptor photobleaching experiments
as an alternative FRET method (Figure S6B).
Next, we used the developed assay to screen a library of 540
microbial extracts selected from a larger extract collection with
over 400,000 members optimized for chemical and structural
diversity. Using a 20% reduction of the characteristic Emax as
hit criterion in our screen we conducted primary and secondary
screens and confirmed 19 and 18 extracts with promising Ras-
and Rab-NANOPS responses, respectively. The responses in
four extracts were shared by both biosensors, while the majority
of active extracts exerted biosensor-specific effects. These
results suggest the existence of selective as well as broad-
spectrum actives (Figure 5A). In follow-up experiments, we
focused on eight extracts, which showed overlapping and/or
strong activity for Ras- and Rab-NANOPS. For several of these
extracts, the activity was enriched in the most hydrophobic
fractions following reversed phase chromatography (Figures
S8A and S8B).
Analysis of themetabolite profiles of the selected hits revealed
that five out of eight extracts contained macrotetrolides, which
are macrocyclic antibiotics known for their ionophoric activity
(Figure 5B) (Graven et al., 1966). Using a mixture of macrotetro-
lides (nonactin, monactin, dinactin, trinactin and tetranactin) in
our cellular FRET assay, we first validated their dose-dependent
action on the Emax response of Ras-NANOPS (Figure 5C). The
IC50 of 1.9 mg/ml suggested that macrotetrolides are active in
the low micromolar range. We next tested, whether macrotetro-
lides can act synergistically to classical inhibitors of protein
prenylation. Indeed, our analysis of the FRET response con-
firmed that macrotetrolides act in concert with compactin and
FTIs, shifting the apparent IC50 down by a factor of two to five
(Figure 5D; Figure S8C).
As ionophores, macrotetrolides can insert into the cellular
membranes. This may impact on the membrane nanostructure,
possibly disrupting nanoclusters harboring small GTPases. To
test this hypothesis, we performed electron microscopic anal-
ysis of Ras-biosensor nanoclustering on plasma membrane-
derived membrane sheets (Prior et al., 2003). As can be seen
in Figure 5E, the macrotetrolides induced a significant and
specific reduction in nanoclustering of the Ras-biosensor
construct (Figures S9A and S9B). This reduction was as high
as that mediated by the cholesterol-extracting agent methyl-
b-cyclodextrin (MbCD), which is known to disperse Ras nano-
clusters (Prior et al., 2003).
The ionophoric activity may have altered the cellular
membrane potential and thus affect membrane localization in
particular of K-ras4B (Gomez and Daniotti, 2007). However,
this was not evidenced by confocal imaging data, which
showed that neither subcellular localization of Ras-NANOPS,td All rights reserved
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Figure 5. Screening of a Natural Product Library with Ras- and Rab-NANOPS Identifies Macrotetrolides as Ras Nanoclustering and Ras
Signaling Disrupting Compounds
(A) Schematic overview of the flow cytometeric 96-well-based high-throughput screen (HTS) of a library of microbial extracts. The number of verified hits per
biosensor is shown in a Venn diagram.
(B) Chemical structure of macrotetrolides.
(C) Dose-response curve of the effect of the mixture of macrotetrolides on the nanoclustering Emax value of Ras-NANOPS expressed in BHK cells (n = 3), IC50 =
1.9 mg/ml.
(D) Two Ras-NANOPS FRET dose-response curves of FTI2628 are shown, with (+ macrotetrolides, 10 mg/ml, solid curve, n = 3, IC50 = 22.3 nM) and without
macrotetrolides (– macrotetrolides, dotted curve, n = 3 IC50 = 45.6 nM).
(E) Apical membrane sheets fromBHK cells expressing Ras-NANOPSwere generated, immunogold labeled with 5 nm anti-GFP antibody and imaged by electron
microscopy. Ripley’s K-function and bootstrap analyses were performed after indicated treatments (untreated, macrotetrolides for 24 hr, methyl-beta-cyclo-
dextrin, MbCD for 1 hr, on n = 16, n = 16 and n = 10 plasma membrane sheets, respectively). Macrotetrolide treatment resulted in a significant decrease in
nanoclustering (p = 0.012) of Ras-NANOPS, whereas, MbCD treatment did not result in a significant decrease (p = 0.42). Average numbers of gold particles per
1 mm2 were consistent between experimental conditions (untreated = 1,023, macrotetrolides = 1,006 and MbCD = 1,229).
(F) EGF-stimulated MAPK response of BHK cells measured by changes in levels of ERK phosphorylation (nR 3, except for 10 mg/ml where n = 2). Cells were
treated for 24 hr with the indicated inhibitors. Compactin was applied at 5 mM. Individual data points (gray dots) and their mean values (horizontal black bars) with
SEM are given in (C), (D), and (F). Statistical analysis in (F) was as described in Figure 1.
See also Figures S5, S6, S7, S8, S9, and S10.
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cantly affected by macrotetrolides.
To test for more subtle effects of the ionophoric activity on
K-ras nanoclustering, we analyzed the effect of macrotetrolides
on the Emax of Rho-NANOPS, which contains a polybasic
membrane anchoring C terminus similar to K-ras, or an analo-
gous K-ras-derived biosensor (Abankwa and Vogel, 2007)
(Figures S9F and S9G). Neither the nanoclustering FRET of
Rho-NANOPS, nor that of the K-ras-derived biosensor was
affected by macrotetrolides. Finally, biochemical experiments
confirmed that overall protein prenylation by farnesyltransferase
or Rab-geranylgeranlytransferase was unaffected by macrote-
trolides (Figures S9D and S9E). In summary, these data sug-
gest that macrotetrolides specifically disrupt nanoclustering of
Ras-NANOPS, while membrane localization of H- and K-ras,
as well as protein prenylation, remains unaffected.
Ras nanoclustering is essential for its signal transmission in
the MAPK pathway (Tian et al., 2007). We therefore examined
the biological effect of macrotetrolides on Ras/MAPK signalingChemistry & Biology 19,activity. In agreement with the importance of Ras nanocluster-
ing for Ras signaling, incubation of BHK cells with macrotetro-
lides decreased the epidermal growth factor(EGF)-induced
ppERK levels dose dependently (Figure 5F). Finally, to get
more information about individual active compounds, we frac-
tionated the macrotetrolide mix by reversed phase HPLC. The
nanocluster-dispersing activity was detected in several frac-
tions, including one containing nonactin and monactin. In fact,
the mixture of these two macrotetrolides could dose-depen-
dently decrease the FRET response with a submicromolar IC50
of approximately 0.32 mM (Figure S9C), which corresponds
to a higher activity than that found for the macrotetrolide mix
(Figure 5C).
In conclusion, using our cellular FRET screen, we have identi-
fied macrotetrolides as submicromolar inhibitors of Ras
membrane nanoclustering. With this mode of action, they can
act synergistically with classical inhibitors, such as compactin
and FTIs, to inhibit functional membrane anchorage of Ras.
Most importantly, this activity is sufficient to significantly866–874, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 871
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upregulated in cancer.
DISCUSSION
We have developed a sensitive high-throughput assay for in vivo
monitoring of the steady-state activity of all three eukaryotic
prenyl-transferases that previously could only be analyzed
in vitro. This direct and quantitative assessment of the inhibition
of selectedmolecular drug targets in the environment of intracel-
lular membranes sets this assay apart from previous develop-
ments. Furthermore, we have demonstrated that the FRET assay
can be used to evaluate such complex sources of bioactive
compounds as microbial extracts. This highlights the robust-
ness, stability, and selectivity of the bioassay and its relevance
to the in vivo situation.
We anticipate that the analysis of membrane anchorage by
FRET can be used for related applications, such as deorphaniza-
tion of the in vivo targets of palmitoyltransferases. This can
be achieved by simple customization of the system, as essen-
tially any nanoclustered polypeptide can be redesigned into
a biosensor.
Our analysis also provides direct evidence of clustering of Rab
GTPases on the nanoscale. The different extent of nanocluster-
ing FRET of Rab5a mutants suggests that Rab5a needs a
specific proteolipid environment on endosomes for nanocluster
formation. This is consistent with the specific set of endosomal
proteins, such as guanine nucleotide exchange factors (GEFs)
and effectors, that were proposed to reinforce Rab5 clustering
(Zerial and McBride, 2001). While the FRET data analysis is
necessarily performed at overexpression levels, we have shown
previously (Abankwa and Vogel, 2007), that high FRET levels that
are consistent with nanoclustering are already achieved at phys-
iological densities of 50–200 proteins per mm2 (Gureasko et al.,
2008). Our Rab nanoclustering FRET data are further supported
by our electron microscopic analysis and the coclustering anal-
ysis with Ras as a well-established nanoclustered protein.
Considering the importance of nanoclustering for Ras signal
transmission and Ras activation (Gureasko et al., 2008; Tian
et al., 2007), and the now suggested significance for the
signaling architecture at least of a subset of small GTPases,
nanoclusters may represent putative drug targets.
Most importantly, we have identified macrotetrolides as sub-
micromolar Ras-NANOPS nanoclustering inhibitors. While the
identified compound class has been known to possess antibiotic
activity for many decades (Graven et al., 1966), their potential to
inhibit Ras nanoclustering andMAPK signaling has only become
apparent through our FRET biosensor assay. The nanocluster
disrupting activity does warrant further development of the
structure class and prompts a closer analysis of other lipophylic
ionophores.
SIGNIFICANCE
Despite three decades of efforts, no specific inhibitor of the
oncoprotein Ras has been developed. While chemical
screening typically relies on biochemical assays, recent
data have emphasized the importance of the membrane
environment of the intact cell for Ras functionality.872 Chemistry & Biology 19, 866–874, July 27, 2012 ª2012 Elsevier LMembrane nanoclustering of Ras molecules is necessary
for their biological activity. Different Ras isoforms laterally
segregate to different nanoclusters from where they appear
to engage signaling pathways specifically. It is therefore
tempting to speculate that Ras nanoclusters may represent
novel, specific anti-Ras drug targets.
To test this idea, we developed three nanocluster FRET
biosensors with the potential to identify classical membrane
targeting inhibitors (e.g., FTIs, statins) and nanoclustering
inhibitors of the three major subfamilies of Ras, Rho, and
Rab GTPases.
Our results show that by using a FRET-based high-
throughput cytometric assay it was possible to identify
specific submicromolar inhibitors of Ras nanoclustering
that also block MAPK signaling. We also provide evidence
that Rab-GTPases are nanoclustered, suggesting that tar-
geting small GTPase nanoclusters could be a novel, generic
approach to block small GTPase signaling. Rab proteins and
their cognate prenyltransferase are recently identified
cancer-drug targets, and our assay represents a cellular
assay that can identify the corresponding inhibitors. This
relatively simple and high-throughput amenable assay has
therefore potential for cellular screening of not only mixed
but also defined chemical libraries. Finally, our biosensor
approach could be extended to probe the cellular activity
of other protein lipid transferases.
EXPERIMENTAL PROCEDURES
Cell Culture
BHK 21 cells (Sigma-Aldrich) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) supplemented with 10% fetal bovine serum,
100 U/ml penicillin G, (Invitrogen, # 15070-063), and 100 U/ml streptomycin
(Invitrogen, #15070-063). HEK293 cells (Sigma-Aldrich) were cultured in
DMEM containing 10% fetal bovine serum (Invitrogen, #26140079), 1% gluta-
mine (Invitrogen, #25030-081), 1% nonessential amino acids (Invitrogen,
#11140050), 100 U/ml penicillin G and 100 U/ml streptomycin and incubated
at 37C with 5% CO2. Transfections were performed with FuGene6 (Roche)
according to the manufacturer’s instructions in a 6-well plate and the cells
transferred to a 96-well plate on the next day with a density of 5 3 104 cells
per well. The compound stocks were dissolved in DMSO (Sigma Aldrich,
#41641) (all, but compactin and NE10790, which were dissolved in water)
and diluted in cell culture medium for experiments to give a final DMSO
concentration below 0.3%. All inhibitors (Table S2) were added to cultured
cells 16 hr after transfection and cultures were incubated for 24 hr. A list of
reagents is provided in the supporting information to this manuscript. The pilot
screening of the 540 bacterial extracts fromMicrobial Screening Technologies
Pty. Ltd. (MST), which represents a large cross-section of chemical diversity,
was performed similarly by diluting the extracts 1:10 in 100 ml cell-assay in
a 96-well plate and incubating them for 24 hr.
Flow Cytometric FRET Analysis
For flow cytometric analysis, cells were detached with 10 mM EDTA in PBS
and fixed in 2% paraformaldehyde (final concentration). The measurements
were performed on a FACS CantoII (BD biosciences) equipped with a high-
throughput sampler, using the following filters for donor (405 nm excitation,
450/50 nm emission filter), acceptor (488 nm, excitation, 585/42 nm emission
filter), and FRET channel (488 nm excitation, 530/30 nm emission filter). The
flow cytometer data were analyzed for FRET with a custom written procedure
in IgorPro5 (Wavemetrics), as described (Abankwa et al., 2008b; Abankwa and
Vogel, 2007). In brief, doublet discrimination was implemented to measure
signals of single cells. For normalized acceptor level calibration, cA, FITC
beads (Bangs Laboratories) with a defined size and fluorescein content were
used as described previously. A mCFP-mCitrine fusion protein was used totd All rights reserved
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a donor mole-fraction, xD = 0.5 ± 0.1 were analyzed. The Emax value was deter-
mined as described (Abankwa et al., 2008b; Abankwa and Vogel, 2007).
Electron Microscopy and Statistical Analyses
Plasmamembrane sheets were generated fromBHK cells, fixedwith 4%para-
formaldehyde and 0.1% glutaraldehyde and labeled with anti-GFP antibody
directly conjugated to 5 nm colloidal gold as described previously (Plowman
et al., 2005; Prior et al., 2003). Electron micrographs of labeled PM sheets
were imaged at 80 kV in a JEOL 1011 transmission electron microscope
(JEOL, Japan) at amagnification of 100,000 times. xy coordinates of gold parti-
cles were determined using ImageJ (Hancock and Prior, 2005; Prior et al.,
2003) and Ripley’s K function statistical analysis was performed on xy coordi-
nates as described previously (Plowman et al., 2005; Prior and Hancock,
2001). Bootstrap tests were employed to compare differences between point
patterns and were performed as described previously (Diggle et al., 2000).
siRNA Knockdown Experiments and RT-PCR Quantification
HEK293 were seeded in a 12-well plate and siRNA transfection was performed
on the next day with Lipofectamine RNAiMax (Invitrogen) according to
the manufacturer’s instructions with a final concentration of 40 nM siRNA in
the medium. Cells were harvested 48 hr after transfection, and RNA extraction
and cDNA synthesis (CellSure, Bioline) were performed according to the
manufacturer’s protocol. The real-time PCR consisted of cDNA template
(diluted 1:20), forward and reverse primers (200 nM final concentration), and
Platinum SYBR Green qPCR Supermix-UDG (Invitrogen) in a total volume of
20 ml. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as
normalization reference. Quantitative real-time PCR was carried out in
triplicate on indicated number of independent templates on a 7500 Real-
Time PCR System (Applied Biosystems). For analysis of the Ct values, the
DDCt method was applied. To test for contamination, standard control
PCRswere performed. For FACS analysis of the knockdown, DNA transfection
of the biosensor constructs with FuGene6 was performed 24 hr after siRNA
transfection. The cells were analyzed for FRET on the flow cytometer as
described above, 48 hr after siRNA transfection. Employed siRNAs are
provided in Table S3.
Data Analysis
The IC50 values for inhibition data were analyzed in GraphPad Prism by
nonlinear regression analysis on log (inhibitor) versus (normalized) response
data using the Marquardt method.
Statistical Analysis
Z0 scores were calculated on the control data in the chemical screen from the
following formula Z0 = 1 – (3 ,spos + 3 , sneg)/(jmpos – mnegj), withspos/neg: SDs of
positive and negative controls, respectively, and mpos/neg: averages of positive
and negative controls, respectively (Zhang et al., 1999). Significant differences
between mean values of inhibitor treated samples and mean values of
untreated samples were analyzed using two-tailed Student’s t tests in Graph-
Pad Prism or Microsoft Excel. Confidence p levels are given and in addition
indicated by asterisks, with *p < 0.05, **p < 0.01, and ***p < 0.001. Note,
that ‘‘untreated’’ and ‘‘compactin’’-treated samples were always significantly
different (p < 0.001). Therefore, for clarity these p levels are not shown.
SUPPLEMENTAL INFORMATION
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